| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 341,059 | 355,218 | 364,892 | 368,172 | | Cost of Revenue | 175,017 | 183,259 | 188,647 | 182,344 | | | Gross Profit | 166,042 | 171,959 | 176,245 | 185,828 | | | Operating Expenses | | Research Development | 4,605 | 4,701 | 1,526 | 1,323 | | Selling General and Administrative | 94,079 | 97,782 | 94,237 | 97,400 | | Non Recurring | 3,892 |
-
|
-
|
-
| | Others | 16,570 | 16,094 | 15,233 | 15,244 | | | | Total Operating Expenses | 119,146 |
-
|
-
|
-
| | | | Operating Income or Loss | 46,896 | 53,382 | 65,249 | 71,861 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,245 | 1,075 | (218) | (1,915) | | Earnings Before Interest And Taxes | 48,141 | 54,457 | 65,031 | 69,946 | | Interest Expense |
-
|
-
|
-
| 537 | | Income Before Tax | 48,141 | 54,457 | 65,031 | 69,409 | | Income Tax Expense | 10,468 | 15,793 | 20,733 | 22,210 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 37,673 | 38,664 | 44,298 | 47,199 | | | Non-recurring Events | | Discontinued Operations |
-
| 19,397 | 271 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,673 | 58,061 | 44,569 | 47,199 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $37,673 | $58,061 | $44,569 | $47,199 |
|
0.01% Nasdaq 
0.22%
Income Statement
